Matthew T. David - 12 Jan 2024 Form 4 Insider Report for CorMedix Inc. (CRMD)

Signature
/s/ Matthew T David
Issuer symbol
CRMD
Transactions as of
12 Jan 2024
Transactions value $
-$18,100
Form type
4
Date filed
17 Jan 2024, 20:10
Previous filing
18 Jan 2023
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Award $0 +50K +1587.3% $0.00 53.2K 12 Jan 2024 Direct F1
transaction CRMD Common Stock Tax liability -$18.1K -5.22K -9.81% $3.47 47.9K 12 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +100K $0.00 100K 12 Jan 2024 Common Stock 100K $3.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F2 These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.